LADD; Sharron

Patent Applications and Registrations

Patent applications and USPTO patent grants for LADD; Sharron.The latest application filed is for "antibodies and assays for detection of folate receptor 1".

Company Profile

3.6.9

LADD; Sharron - Gregory MI
Ladd; Sharron - Burlington MA
Ladd; Sharron - Burlingotn MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies And Assays For Detection Of Folate Receptor 1 App 20220169745 - AB; Olga ; et al.	2022-06-02
Methods For Increasing Efficacy Of Folr1 Cancer Therapy App 20220143208 - CARRIGAN; Christina N. ; et al.	2022-05-12
Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody Grant 11,198,736 - Ab , et al. December 14, 2	2021-12-14
Methods for increasing efficacy of FOLR1 cancer therapy Grant 11,135,305 - Carrigan , et al. October 5, 2	2021-10-05
Antibodies And Assays For Detection Of Folate Receptor 1 App 20200325240 - AB; Olga ; et al.	2020-10-15
Methods of using antibodies to detect folate receptor 1 (FOLR1) Grant 10,544,230 - Ab , et al. Ja	2020-01-28
Antibodies And Assays For Detection Of Folate Receptor 1 App 20190023805 - AB; Olga ; et al.	2019-01-24
Methods for Increasing Efficacy of FOLR1 Cancer Therapy App 20180200383 - Carrigan; Christina N. ; et al.	2018-07-19
Antibodies And Assays For Detection Of Folate Receptor 1 App 20170306041 - AB; Olga ; et al.	2017-10-26
Monoclonal antibodies for detection of folate receptor 1 Grant 9,637,547 - Ab , et al. May 2, 2	2017-05-02
Antibodies and Assays for Detection of Folate Receptor 1 App 20150093388 - AB; Olga ; et al.	2015-04-02
Methods for Increasing Efficacy of FOLR1 Cancer Therapy App 20140363453 - CARRIGAN; Christina N. ; et al.	2014-12-11
Methods for increasing efficacy of FOLR1 cancer therapy Grant 8,709,432 - Carrigan , et al. April 29, 2	2014-04-29
Methods for Increasing Efficacy of FOLR1 Cancer Therapy App 20120282175 - Carrigan; Christina N. ; et al.	2012-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.